{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:46:14Z","timestamp":1791996374282,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-026-01804-9","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:23:31Z","timestamp":1784157811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of factors associated with intraductal carcinoma of the prostate"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4505-7513","authenticated-orcid":false,"given":"Motoki","family":"Yamagishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey M.","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiko","family":"Yamochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Oshinomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Fukagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"1","key":"1804_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A, Cancer statistics. CA Cancer J Clin 2024 Jan-Feb. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin 2024 Jan-Feb"},{"issue":"3","key":"1804_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1804_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0022-5347(17)60451-8","volume":"109","author":"RK Rhamy","year":"1973","unstructured":"Rhamy RK, Buchanan RD, Spalding MJ. Intraductal carcinoma of the prostate gland. J Urol. 1973;109(3):457\u201360.","journal-title":"J Urol"},{"issue":"7","key":"1804_CR4","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO;2-Y","volume":"56","author":"J Kovi","year":"1985","unstructured":"Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic carcinoma. Cancer. 1985;56(7):1566\u201373.","journal-title":"Cancer"},{"key":"1804_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199607000-00003","author":"JE McNeal","year":"1996","unstructured":"McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol. 1996. https:\/\/doi.org\/10.1097\/00000478-199607000-00003.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1804_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/(SICI)1097-0045(20000401)43:1<11::AID-PROS3>3.0.CO;2-B","volume":"43","author":"RJ Cohen","year":"2000","unstructured":"Cohen RJ, McNeal JE, Baillie T. Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression. Prostate. 2000;43(1):11\u20139.","journal-title":"Prostate"},{"issue":"12","key":"1804_CR7","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/modpathol.3800702","volume":"19","author":"CC Guo","year":"2006","unstructured":"Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod Pathol. 2006;19(12):1528\u201335.","journal-title":"Mod Pathol"},{"key":"1804_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/pros.23438","volume":"78","author":"M Kato","year":"2018","unstructured":"Kato M, Kimura K, Hirakawa A, et al. Prognostic parameter for high risk prostate cancer patients at initial presentation. Prostate. 2018;78:11\u20136.","journal-title":"Prostate"},{"issue":"5","key":"1804_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/PAS.0000000000001417","volume":"44","author":"JS Gandhi","year":"2020","unstructured":"Gandhi JS, Smith SC, Paner GP, McKenney JK, Sekhri R, Osunkoya AO, et al. Reporting practices and resource utilization in the era of intraductal carcinoma of the prostate: a survey of genitourinary subspecialists. Am J Surg Pathol. 2020;44(5):673\u201380.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"1804_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/jclinpath-2016-203658","volume":"69","author":"M Varma","year":"2016","unstructured":"Varma M, Egevad L, Algaba F, Berney D, Bubendorf L, Camparo P, et al. Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists. J Clin Pathol. 2016;69(10):852\u20137.","journal-title":"J Clin Pathol"},{"key":"1804_CR11","first-page":"10","volume":"53","author":"T Vkajnic","year":"2021","unstructured":"Vkajnic T, Bubendorf L. Molecular pathology of prostate cancer: a practical approach. Pathology. 2021;53:10\u201322.","journal-title":"Pathology"},{"issue":"1","key":"1804_CR12","volume":"132","author":"H Dudipala","year":"2026","unstructured":"Dudipala H, Nazari SS, Werneck da Cunha I, et al. Molecular alteration profiles characterize intraductal carcinoma of the prostate. Cancer (Basel). 2026;132(1):e70238.","journal-title":"Cancer (Basel)"},{"issue":"4","key":"1804_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","volume":"41","author":"JI Epstein","year":"2014","unstructured":"Epstein JI, Amin MB, Reuter VE, Humphrey PA. Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2014;41(4):e1\u20137.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1804_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","volume":"145","author":"JI Epstein","year":"2021","unstructured":"Epstein JI, Amin MB, Fine SW, et al. The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer. Arch Pathol Lab Med. 2021;145(4):461\u201393.","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"1804_CR15","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","volume":"44","author":"GJLH van Leenders","year":"2019","unstructured":"van Leenders GJLH, van der Kwast TH, Grignon DJ, Evans AJ, Kristiansen G, Kweldam CF, et al. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2019;44(8):e87\u201399.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1804_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/his.14132","volume":"77","author":"D Chen-Maxwell","year":"2020","unstructured":"Chen-Maxwell D, Prendeville S. Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies. Histopathology. 2020;77(3):503\u20137.","journal-title":"Histopathology"},{"issue":"2","key":"1804_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.euo.2023.06.007","volume":"7","author":"MR Chappidi","year":"2024","unstructured":"Chappidi MR, Sj\u00f6str\u00f6m M, Greenland NY, Cowan JE, Baskin AS, Shee K, et al. Transcriptomic heterogeneity of expansile cribriform and other Gleason Pattern 4 prostate cancer subtypes. Eur Urol Oncol. 2024;7(2):222\u201330.","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"1804_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/bco2.201","volume":"4","author":"E Shiomi","year":"2022","unstructured":"Shiomi E, Kato R, Kanehira M, Takata R, Sugimura J, Nakamura Y, et al. Cribriform pattern in prostate tissues: predictor for intraductal carcinoma of the prostate based on biopsy and radical prostatectomy pathology. BJUI Compass. 2022;4(3):339\u201345.","journal-title":"BJUI Compass"},{"issue":"3","key":"1804_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.prnil.2020.02.001","volume":"8","author":"UM Haroon","year":"2020","unstructured":"Haroon UM, O\u2019Grady-Coyne S, Davis NF, Gullmann C, Forde JC, Smyth GP, et al. Intraductal carcinoma of the prostate in an Irish prostate cancer patient cohort-an aggressive pathology and a strong familial link. Prostate Int. 2020;8(3):107\u201311.","journal-title":"Prostate Int"},{"key":"1804_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00910-3","author":"RM Bernardino","year":"2024","unstructured":"Bernardino RM, Yin LB, Lajkosz K, Cockburn JG, Wettstein M, Sayyid RK, et al. Undetected cribriform and intraductal prostate cancer at biopsy is associated with adverse outcomes. Prostate Cancer Prostatic Dis. 2024. https:\/\/doi.org\/10.1038\/s41391-024-00910-3.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"1804_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051372","volume":"15","author":"R Osiecki","year":"2023","unstructured":"Osiecki R, Kozikowski M, Sarecka-Hujar B, Pyzlak M, Dobruch J. Prostate cancer morphologies: cribriform pattern and intraductal carcinoma relations to adverse pathological and clinical outcomes-systematic review and meta-analysis. Cancers (Basel). 2023;15(5):1372.","journal-title":"Cancers (Basel)"},{"issue":"22","key":"1804_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225319","volume":"15","author":"J Surintrspanont","year":"2023","unstructured":"Surintrspanont J, Zhou M. Intraductal carcinoma of the prostate: to grade or not to grade. Cancers (Basel). 2023;15(22):5319.","journal-title":"Cancers (Basel)"},{"key":"1804_CR23","doi-asserted-by":"crossref","unstructured":"Szentirmai E, Giannico GA. Intraductal carcinoma of the prostate. Pathologica 2020 Mar.112(1):17\u201324.","DOI":"10.32074\/1591-951X-5-20"},{"issue":"4","key":"1804_CR24","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/his.12198","volume":"63","author":"K Watts","year":"2013","unstructured":"Watts K, Li J, Magi-Galluzzi C, Zhou M. Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study. Histopathology. 2013;63(4):574\u20139.","journal-title":"Histopathology"},{"issue":"3","key":"1804_CR25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/his.13747","volume":"74","author":"M Masoomian","year":"2019","unstructured":"Masoomian M, Downes MR, Sweet J, Cheung C, Evans AJ, Fleshner N, et al. Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set. Histopathology. 2019;74(3):474\u201382.","journal-title":"Histopathology"},{"issue":"1","key":"1804_CR26","doi-asserted-by":"publisher","first-page":"48.e11","DOI":"10.1016\/j.urolonc.2022.09.025","volume":"41","author":"G Pahouja","year":"2023","unstructured":"Pahouja G, Patel HD, Desai S, Rac G, Cheng T, Okabe Y, et al. The rising incidence of ductal adenocarcinoma and intraductal carcinoma of the prostate: diagnostic accuracy of biopsy, MRI-visibility, and outcomes. Urol Oncol. 2023;41(1):48.e11-48.e18.","journal-title":"Urol Oncol"},{"issue":"4","key":"1804_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.clgc.2023.03.010","volume":"21","author":"TJ Nelson","year":"2023","unstructured":"Nelson TJ, Kumar A, Nalawade V, Nonato T, Shabaik A, Roma A, et al. Associations between intraductal prostate cancer and metastases following radical prostatectomy in men with prostate cancer in the Veterans Affairs Database. Clin Genitourin Cancer. 2023;21(4):452\u20138.","journal-title":"Clin Genitourin Cancer"},{"issue":"11","key":"1804_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/pin.13369","volume":"73","author":"T Ito","year":"2023","unstructured":"Ito T, Takahara T, Taniguchi N, Yamamoto Y, Satou A, Ohashi A, et al. PTEN loss in intraductal carcinoma of the prostate has low incidence in Japanese patients. Pathol Int. 2023;73(11):542\u20138.","journal-title":"Pathol Int"},{"issue":"8","key":"1804_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003281","volume":"17","author":"AA Grosset","year":"2020","unstructured":"Grosset AA, Dallaire F, Nguyen T, Birlea M, Wong J, Daoust F, et al. Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: a diagnostic accuracy case-control study with multicohort validation. PLoS Med. 2020;17(8):e1003281.","journal-title":"PLoS Med"},{"key":"1804_CR30","doi-asserted-by":"crossref","unstructured":"Trinh VQ, Benzerdjeb N, Chagnon-Monarque S, Dionne N, Delouya G, Kougioumoutzakis A, Sirois J, Albadine R, Latour M, Mes-Masson AM, Hovington H, Bergeron A, Zorn KC, Fradet Y, Saad F, Taussky D, Trudel D. Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate. Radiat Oncol. 2019;25(1):60.","DOI":"10.1186\/s13014-019-1267-3"},{"issue":"10","key":"1804_CR31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/pros.23818","volume":"79","author":"M Kato","year":"2019","unstructured":"Kato M, Hirakawa A, Kobayashi YM, Yamamoto A, Ishida R, Sano T, et al. The influence of the presence of intraductal carcinoma of the prostate on the grade group system\u2019s prognostic performance. Prostate. 2019;79(10):1065\u201370.","journal-title":"Prostate"},{"issue":"12","key":"1804_CR32","doi-asserted-by":"publisher","first-page":"673.e9","DOI":"10.1016\/j.urolonc.2017.08.015","volume":"35","author":"BF Dinerman","year":"2017","unstructured":"Dinerman BF, Khani F, Golan R, Bernstein AN, Cosiano MF, Margolis DJ, et al. Population-based study of the incidence and survival for intraductal carcinoma of the prostate. Urol Oncol. 2017;35(12):673.e9-673.e14.","journal-title":"Urol Oncol"},{"key":"1804_CR33","unstructured":"Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between precursor-like and regular type lesions. Int J Clin Exp Pathol. 2014 ;15(5):2518\u201326."},{"issue":"15","key":"1804_CR34","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/pros.24215","volume":"81","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhu S, Zhao J, Nie L, Chen X, Zhang M, et al. The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer. Prostate. 2021;81(15):1191\u2013201.","journal-title":"Prostate"},{"issue":"3","key":"1804_CR35","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s10147-017-1235-6","volume":"23","author":"A Yamamoto","year":"2018","unstructured":"Yamamoto A, Kato M, Matsui H, Ishida R, Kimura T, Funahashi Y, et al. Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate. Int J Clin Oncol. 2018;23(3):584\u201390.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"1804_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/modpathol.2015.146","volume":"29","author":"M Kato","year":"2016","unstructured":"Kato M, Tsuzuki T, Kimura K, Hirakawa A, Kinoshita F, Sassa N, et al. The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation. Mod Pathol. 2016;29(2):166\u201373.","journal-title":"Mod Pathol"},{"issue":"12","key":"1804_CR37","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1007\/s10147-020-01756-0","volume":"25","author":"M Kato","year":"2020","unstructured":"Kato M, Hirakawa A, Kobayashi Y, Yamamoto A, Naito Y, Tochigi K, et al. Effect of core needle biopsy number on intraductal carcinoma of the prostate (IDC-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer. Int J Clin Oncol. 2020;25(12):2130\u20137.","journal-title":"Int J Clin Oncol"},{"key":"1804_CR38","doi-asserted-by":"crossref","unstructured":"Porter LH, Hashimoto K, Lawrence MG, Pezaro C, Clouston D, Wang H, Papargiris M, Thorne H, Li J, kConFab. Ryan A, Norden S, Moon D, Bolton DM, Sengupta S, Frydenberg M, Murphy DG, Risbridger GP, Taylor RA. Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells. BJU Int. 2018;121(6):971\u20138.","DOI":"10.1111\/bju.14043"},{"issue":"4","key":"1804_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/pros.24462","volume":"83","author":"Y Naito","year":"2023","unstructured":"Naito Y, Kato M, Kawanishi H, Yamamoto A, Sakamoto F, Hirabayashi H, et al. Clinical utility of intraductal carcinoma of the prostate in treatment selection for metastatic hormone-sensitive prostate cancer. Prostate. 2023;83(4):307\u201315.","journal-title":"Prostate"},{"issue":"3","key":"1804_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/iju.13514","volume":"25","author":"Y Murata","year":"2018","unstructured":"Murata Y, Tatsugami K, Yoshikawa M, Hamaguchi M, Yamada S, Hayakawa Y, et al. Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer. Int J Urol. 2018;25(3):284\u20139.","journal-title":"Int J Urol"},{"issue":"6","key":"1804_CR41","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/bju.14398","volume":"122","author":"J Zhao","year":"2018","unstructured":"Zhao J, Sun G, Liao B, Zhang X, Armstrong CM, Yin X, et al. Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer. BJU Int. 2018;122(6):994\u20131002.","journal-title":"BJU Int"},{"issue":"2","key":"1804_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00428-017-2241-9","volume":"472","author":"TA Flood","year":"2018","unstructured":"Flood TA, Schieda N, Sim J, Breau RH, Morash C, Belanger EC, et al. Evaluation of tumor morphologies and association with biochemical recurrence after radical prostatectomy in grade group 5 prostate cancer. Virchows Arch. 2018;472(2):205\u201312.","journal-title":"Virchows Arch"},{"issue":"6","key":"1804_CR43","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/pros.22786","volume":"74","author":"K Kimura","year":"2014","unstructured":"Kimura K, Tsuzuki T, Kato M, Saito AM, Sassa N, Ishida R, et al. Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens. Prostate. 2014;74(6):680\u20137.","journal-title":"Prostate"},{"issue":"8","key":"1804_CR44","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/pros.23326","volume":"77","author":"T Saeter","year":"2017","unstructured":"Saeter T, Vlatkovic L, Waaler G, Servoll E, Nesland JM, Axcrona K, et al. Intraductal carcinoma of the prostate on diagnostic needle biopsy predicts prostate cancer mortality: a population-based study. Prostate. 2017;77(8):859\u201365.","journal-title":"Prostate"},{"issue":"5","key":"1804_CR45","doi-asserted-by":"publisher","first-page":"e00048","DOI":"10.1097\/JU9.0000000000000294","volume":"3","author":"T Sasaki","year":"2025","unstructured":"Sasaki T, Semba R, Kobayashi I, et al. Regional discrepancy in the incidence of intraductal carcinoma of the prostate in radical prostatectomy specimens. JU Open Plus. 2025;3(5):e00048.","journal-title":"JU Open Plus"},{"issue":"5","key":"1804_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00428-019-02544-6","volume":"474","author":"M Varma","year":"2019","unstructured":"Varma M, Delahunt B, Egevad L, Samaratunga H, Kristiansen G. Intraductal carcinoma of the prostate: a critical re-appraisal. Virchows Arch. 2019;474(5):525\u201334.","journal-title":"Virchows Arch"},{"issue":"6","key":"1804_CR47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.anndiagpath.2014.08.010","volume":"18","author":"KA Iczkowski","year":"2014","unstructured":"Iczkowski KA, Egevad L, Ma J, Harding-Jackson N, Algaba F, Billis A, et al. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists. Ann Diagn Pathol. 2014;18(6):333\u201342.","journal-title":"Ann Diagn Pathol"},{"key":"1804_CR48","doi-asserted-by":"crossref","unstructured":"Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, Bray F. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012 ;61(6):1079\u201392.","DOI":"10.1016\/j.eururo.2012.02.054"},{"issue":"9","key":"1804_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.5732\/cjc.011.10324","volume":"31","author":"T Kimura","year":"2012","unstructured":"Kimura T. East meets west: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians. Chin J Cancer. 2012;31(9):421\u20139.","journal-title":"Chin J Cancer"},{"issue":"1","key":"1804_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-023-01345-z","volume":"23","author":"R Semba","year":"2023","unstructured":"Semba R, Uchida K, Hirokawa Y, Shiraishi T, Onishi T, Sasaki T, et al. Short-term prognosis of low-risk prostate cancer patients is favorable despite the presence of pathological prognostic factors: a retrospective study. BMC Urol. 2023;23(1):174.","journal-title":"BMC Urol"},{"issue":"4","key":"1804_CR51","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.juro.2010.06.017","volume":"184","author":"BD Robinson","year":"2010","unstructured":"Robinson BD, Epstein JI. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings. J Urol. 2010;184(4):1328\u201333.","journal-title":"J Urol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-026-01804-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01804-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01804-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:02:52Z","timestamp":1791993772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-026-01804-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1804"],"URL":"https:\/\/doi.org\/10.1186\/s13000-026-01804-9","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The principles of the Helsinki Declaration were followed. The requirement for written informed consent was waived due to the retrospective study. Patients were provided with opt-out information on the website in Japan.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"76"}}